Exane Derivatives’s Lam Research LRCX Stock Holding History

Exane Derivatives’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-760	Closed	-$40.9K	–	871
2022 Q1	$40.9K	Hold	760	–	–	0.01%	592
2021 Q4	$54.7K	Buy	+760	New	+$47.6K	0.01%	485
2021 Q2	–	Sell	-370	Closed	-$22K	–	1070
2021 Q1	$22K	Sell	370 -290	-44%	-$15.8K	0.01%	563
2020 Q4	$31.2K	Sell	660 -30,260	-98%	-$1.27M	0.01%	494
2020 Q3	$1.03M	Buy	30,920 +29,650	+2,335%	+$1.02M	0.3%	78
2020 Q2	$41.1K	Sell	1,270 -590	-32%	-$16.1K	0.01%	368
2020 Q1	$44.6K	Sell	1,860 -2,000	-52%	-$57.6K	0.01%	361
2019 Q4	$115K	Sell	3,860 -2,280	-37%	-$60.5K	0.02%	305
2019 Q3	$142K	Sell	6,140 -700	-10%	-$14.7K	0.03%	286
2019 Q2	$128K	Buy	6,840 +6,180	+936%	+$117K	0.02%	299
2019 Q1	$11.8K	Sell	660 -2,700	-80%	-$45.1K	﹤0.01%	383
2018 Q4	$45.7K	Sell	3,360 -14,000	-81%	-$201K	0.01%	367
2018 Q3	$263K	Sell	17,360 -115,230	-87%	-$1.97M	0.05%	226
2018 Q2	$2.29M	Buy	132,590 +126,360	+2,028%	+$2.43M	0.38%	58
2018 Q1	$122K	Sell	6,230 -121,890	-95%	-$2.41M	0.02%	277
2017 Q4	$2.36M	Buy	+128,120	New	+$2.52M	0.41%	42
2017 Q3	–	Sell	-20	Closed	-$283	–	618
2017 Q2	$283	Buy	20 +10	+100%	+$147	﹤0.01%	523
2017 Q1	$128	Sell	10 -384,620	-100%	-$4.52M	﹤0.01%	482
2016 Q4	$4.07M	Buy	384,630 +382,430	+17,383%	+$3.88M	0.8%	32
2016 Q3	$20.8K	Buy	+2,200	New	+$20K	﹤0.01%	355
2015 Q4	–	Sell	-2,549,700	Closed	-$16.7M	–	551
2015 Q3	$16.7M	Buy	+2,549,700	New	+$18.7M	2.11%	24

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Exane Derivatives's LRCX Position: Q2 2022 in Review

Exane Derivatives sold out of Lam Research (LRCX) in Q2 2022, closing a stake of 760 shares — an estimated $40.9K sold.

Exane Derivatives first reported a position in LRCX in Q3 2015 and held it in 21 quarters. The position peaked at $16.7M in Q3 2015. 1,307 funds tracked by Wall St. Rank hold LRCX as of Q2 2022.

Exane Derivatives reported no remaining Lam Research position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 760 Lam Research shares in Q2 2022, an estimated $40.9K.
Exane Derivatives first reported a position in Lam Research in Q3 2015 and held it in 21 quarters.
Exane Derivatives's Lam Research position peaked at $16.7M in Q3 2015.
1,307 funds tracked by Wall St. Rank held Lam Research as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.